SCHEMBL6872027

SCHEMBL6872027

NC(=O)c1cc(-c2cccnc2)no1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2E1 P05181 1/20 0.57
CYP2A6 P11509 1/20 0.57
CYP2C9 P11712 1/20 0.57
CYP2B6 P20813 1/20 0.57
CYP2C19 P33261 1/20 0.57
MKNK1 Q9BUB5 7/20 0.51
MKNK2 Q9HBH9 7/20 0.51
NAMPT P43490 1/20 0.51
USP30 Q70CQ3 1/20 0.48
LOXL2 Q9Y4K0 1/20 0.48
KMT2A Q03164 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
IKBKB O14920 1/20 0.47
BRAF P15056 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
RET P07949 1/20 0.46
F7 P08709 1/20 0.46
F3 P13726 1/20 0.46
SARM1 Q6SZW1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30516607 1.00 CYP2E1 (0.57) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL3986274 0.94 MKNK1 (0.57) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL3983330 0.93 KMO (0.51) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL370074 0.86 CYP2E1 (0.55) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL30516614 0.86 CYP2E1 (0.55) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL23930645 0.84 CYP2A6 (0.54) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL368446 0.84 CYP2C9 (0.54) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL3985673 0.83 RAB9A (0.64) CYP2C9CYP2C19KMT2ARAB9ASMN1; SMN2
SCHEMBL4277897 0.83 TP53 (0.45) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL2112340 0.81 RAB9A (0.74) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1119568-B1 4,5-DIHYDRO-ISOXAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL USE JANSSEN PHARMACEUTICA NV (BE) 2004-02-18 EP claimed